NL191332C - Farmaceutisch preparaat met de ethylester van (all-Z)-5,8,11,14,17-eicosapentaeenzuur. - Google Patents

Farmaceutisch preparaat met de ethylester van (all-Z)-5,8,11,14,17-eicosapentaeenzuur.

Info

Publication number
NL191332C
NL191332C NL7904144A NL7904144A NL191332C NL 191332 C NL191332 C NL 191332C NL 7904144 A NL7904144 A NL 7904144A NL 7904144 A NL7904144 A NL 7904144A NL 191332 C NL191332 C NL 191332C
Authority
NL
Netherlands
Prior art keywords
ethyl ester
pharmaceutical preparation
eicosapentaenoic acid
eicosapentaenoic
acid
Prior art date
Application number
NL7904144A
Other languages
English (en)
Dutch (nl)
Other versions
NL7904144A (nl
NL191332B (nl
Original Assignee
Mochida Pharm Co Ltd
Nippon Suisan Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB2357578A external-priority patent/GB1604554A/en
Application filed by Mochida Pharm Co Ltd, Nippon Suisan Kaisha Ltd filed Critical Mochida Pharm Co Ltd
Publication of NL7904144A publication Critical patent/NL7904144A/xx
Publication of NL191332B publication Critical patent/NL191332B/xx
Application granted granted Critical
Publication of NL191332C publication Critical patent/NL191332C/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C15/00Butter; Butter preparations; Making thereof
    • A23C15/12Butter preparations
    • A23C15/126Butter containing a minority of vegetable oils; Enrichment of butter with fatty acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013Other fatty acid esters, e.g. phosphatides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NL7904144A 1978-05-26 1979-05-25 Farmaceutisch preparaat met de ethylester van (all-Z)-5,8,11,14,17-eicosapentaeenzuur. NL191332C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2357578A GB1604554A (en) 1978-05-26 1978-05-26 Pharmaceutical and food formulations
GB2357478 1978-05-26

Publications (3)

Publication Number Publication Date
NL7904144A NL7904144A (nl) 1979-11-28
NL191332B NL191332B (nl) 1995-01-02
NL191332C true NL191332C (nl) 1995-06-01

Family

ID=26256599

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7904144A NL191332C (nl) 1978-05-26 1979-05-25 Farmaceutisch preparaat met de ethylester van (all-Z)-5,8,11,14,17-eicosapentaeenzuur.

Country Status (13)

Country Link
JP (1) JPS5515444A (enrdf_load_stackoverflow)
AU (1) AU527784B2 (enrdf_load_stackoverflow)
CA (1) CA1151068A (enrdf_load_stackoverflow)
CH (1) CH644267A5 (enrdf_load_stackoverflow)
DE (1) DE2831507A1 (enrdf_load_stackoverflow)
ES (1) ES480921A0 (enrdf_load_stackoverflow)
FR (1) FR2426461A1 (enrdf_load_stackoverflow)
IE (1) IE48287B1 (enrdf_load_stackoverflow)
IL (1) IL55227A (enrdf_load_stackoverflow)
IT (1) IT1116505B (enrdf_load_stackoverflow)
NL (1) NL191332C (enrdf_load_stackoverflow)
NZ (1) NZ187908A (enrdf_load_stackoverflow)
SE (1) SE448678B (enrdf_load_stackoverflow)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5735512A (en) * 1980-06-27 1982-02-26 Nippon Oil & Fats Co Ltd Preventive and remedy for thrombosis
JPS59172416A (ja) * 1983-03-18 1984-09-29 Terumo Corp 脂肪輸液
FR2548021B1 (fr) * 1983-06-29 1986-02-28 Dick P R Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
JPS60132916A (ja) * 1983-12-21 1985-07-16 Nisshin Oil Mills Ltd:The 血栓症予防食品または医薬品
US4752618A (en) * 1984-07-12 1988-06-21 New England Deaconess Hospital Method of minimizing efects of infection through diet
JPH0748991B2 (ja) * 1984-08-29 1995-05-31 日本油脂株式会社 経管栄養組成物
GB8710780D0 (en) * 1987-05-07 1987-06-10 Scras Opthalmological application of eicosapentaenoic acid
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
US5922345A (en) * 1990-12-07 1999-07-13 Scotia Holdings Plc Nutrition
WO1993020717A2 (en) * 1992-04-13 1993-10-28 Research Corporation Technologies, Inc. Reducing gastrointestinal irritation in infant nutrition
NL9401743A (nl) * 1994-10-20 1996-06-03 Prospa Bv Zouten van aminoalcoholen en farmaceutische formuleringen die deze bevatten.
DE19503993A1 (de) * 1995-02-08 1996-08-14 Johann Friedrich Dr Med Desaga Verwendung eines Produktes zur enteralen Versorgung mit Lebensmittelinhaltsstoffen oder Arzneimittelinhaltsstoffen
DE10056351A1 (de) * 2000-11-14 2002-05-29 Weylandt Karsten Henrich Pharmazeutisches Präparat
GB0403247D0 (en) 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
LT3278665T (lt) 2009-04-29 2020-12-10 Amarin Pharmaceuticals Ireland Limited Stabili farmacinė kompozicija ir jos panaudojimo būdai
MY205872A (en) 2009-04-29 2024-11-18 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising omega-3 fatty acids
PT2443246T (pt) 2009-06-15 2018-03-14 Amarin Pharmaceuticals Ie Ltd Composições e métodos para reduzir os triglicéridos sem aumentar os níveis de ldl-c num indivíduo em terapia de estatinas concomitante
BR112012006692B8 (pt) 2009-09-23 2021-05-25 Amarin Corp Plc composição farmacêutica compreendendo um derivado de hidróxi de atorvastatina e um óleo compreendendo etil eicosapentaenoato ou etil docosahexaenoato
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US20130131170A1 (en) 2011-11-07 2013-05-23 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
WO2013103958A1 (en) 2012-01-06 2013-07-11 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering levels of high-sensitivity (hs-crp) in a subject
SG10201913647QA (en) 2012-06-29 2020-03-30 Amarin Pharmaceuticals Ie Ltd Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
US20150265566A1 (en) 2012-11-06 2015-09-24 Amarin Pharmaceuticals Ireland Limited Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
SG10201706205RA (en) 2013-02-06 2017-08-30 Agency Science Tech & Res Methods for reducing aggregate levels in protein preparations by treatment with thio-heterocyclic cations
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
US10172818B2 (en) 2014-06-16 2019-01-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
WO2018213663A1 (en) 2017-05-19 2018-11-22 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
EP4056176B1 (en) 2018-09-24 2024-04-24 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of cardiovascular events in a subject

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE319677B (enrdf_load_stackoverflow) * 1965-03-27 1970-01-19 Sumitomo Chemical Co
FR2097036A1 (en) * 1970-07-29 1972-03-03 Sopharga Lab Lipids contg fatty acids - for treatment of atheroslerosis
GB1476624A (en) * 1973-05-30 1977-06-16 Cepbepe Tranquiliser medicaments
GB1580444A (en) * 1976-11-04 1980-12-03 Bio Oil Res Pharmaceutical compositions
JPS6257605A (ja) * 1985-09-05 1987-03-13 Kaizuka Kazutoshi 多元素鉱物からの有効成分抽出方法

Also Published As

Publication number Publication date
FR2426461B1 (enrdf_load_stackoverflow) 1983-02-11
DE2831507A1 (de) 1979-11-29
NL7904144A (nl) 1979-11-28
JPS5515444A (en) 1980-02-02
ES8104983A1 (es) 1981-05-16
AU3808478A (en) 1980-01-17
DE2831507C2 (enrdf_load_stackoverflow) 1989-07-13
NL191332B (nl) 1995-01-02
ES480921A0 (es) 1981-05-16
IT1116505B (it) 1986-02-10
NZ187908A (en) 1984-05-31
FR2426461A1 (fr) 1979-12-21
CH644267A5 (en) 1984-07-31
IE48287B1 (en) 1984-11-28
SE448678B (sv) 1987-03-16
IE791023L (en) 1979-11-26
SE7904570L (sv) 1979-11-27
CA1151068A (en) 1983-08-02
IT7947717A0 (it) 1979-01-19
IL55227A (en) 1982-12-31
AU527784B2 (en) 1983-03-24
IL55227A0 (en) 1978-09-29

Similar Documents

Publication Publication Date Title
NL191332C (nl) Farmaceutisch preparaat met de ethylester van (all-Z)-5,8,11,14,17-eicosapentaeenzuur.
NO862734L (no) Fremgangsmaate for fremstilling av hyaluronsyreestere.
FI791088A7 (fi) 4-halogeeni-3-oksoandrost-4-eenien 17 - tiokarboksyylihappoestereitä.
FI833062A7 (fi) Arakidonihappoanalogit tulehduksia ja allergioita torjuvina aineina.
RO86355A (ro) Procedeu pentru prepararea(s)-epimerului esterului acidului 7-beta-malonamida-7-alfa-meto0i-3-tetrazoliltiometil-1-detia-1-o0a-3-cefem-4-carbo0ilic
NL178247C (nl) Werkwijze voor de bereiding van butaandicarbonzure esters.
NO147949C (no) Kontinuerlig fremgangsmaate for fremstilling av karboksylpersyrer.
ES513831A0 (es) "procedimiento para la preparacion de esteres carboxilicos de 6-hidroxi-2-benzotiazolsulfonamida".
NL7900264A (nl) 4-pyridon-3-carbonzuurderivaten alsmede de bereiding ervan.
DK153279A (da) 1,3-dibenzoesyreestere af 17alfa-ethynyl-7alfa-methyl-1,3,5(10)-oestratrien-1,3,17beta-trioler samt fremgangsmaade til fremstilling deraf
TR20212A (tr) Stabilize azulmik asidler,imallerine mahsus usuller ve kullanilmalari
NL189910C (nl) Werkwijze voor de bereiding van racemisch p-hydroxyamandelzuur.
IL57591A0 (en) The preparation of chlorostyryl-cyclopropane carboxylic acid derivatives
BE879937A (fr) Procede de preparation d'acides alpha-omega-dicarboxyliques
BE888336A (nl) Werkwijze ter bereinding van cyclopropaan-carbonzure esterderivaten,
NO820924L (no) Fremgangsmaate for fremstilling av klormetylestere av penicillansyrer.
NL7701641A (nl) Werkwijze voor de bereiding van een cyclo- propaancarbonzuurester.
NL184516C (nl) Werkwijze voor de bereiding van zouten van pyrodruivenzuur.
FI803873A7 (fi) Propionihappoestereitä.
NL7700814A (nl) Werkwijze voor de bereiding van zeer zuiver tereftaalzuur.
JPS5515472A (en) 22cyclopropyllpyrimidinee44yllthionophosphoric acid esters*their manufacture and their use as insecticide and miticide
IL60604A (en) 4-fluoro-3-bromo-benzoyl-fluoride,its preparation and its use for the preparation of the alpha-cyano-4-fluoro-3-phenoxybenzyl ester of permethric acid
NL7709502A (nl) Werkwijze voor de bereiding van 17(beta)-hydroxy- -3-oxo-17(alpha)-pregn-4-een-21-carbonzuur gamma- -lacton.
AR221386A1 (es) Procedimiento para la preparacion de esteres basicos de acidos hidroxiciclohexancarboxilicos sustituidos
NL7713616A (nl) Werkwijze voor de bereiding van 0.0-dialkyl- -s-(n-methylcarboxamidomethyl)-thiolfosfor- zuuresters.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BA A request for search or an international-type search has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: BANG EN DR. JORN DYERBERG. DR. HANS OLAF -

BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: MOCHIDA PHARMACEUTICAL CO., LTD. EN NIPPON SUISAN

V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 19990525